𝐏𝐚𝐤𝐢𝐬𝐭𝐚𝐧 𝐚𝐧𝐝 𝐂𝐡𝐢𝐧𝐚 unite to build an advanced antibiotic plant driving innovation, boosting healthcare, and shaping a healthier tomorrow. As proud members of PPMA, Citi Pharma’s milestone reflects the collective strength of Pakistan’s pharmaceutical industry in advancing global healthcare.
Pakistan and China Healthcare Collaboration Read More »
Pakistan’s pharmaceutical industry is making waves internationally, fueled by its high-quality manufacturing and a significant rise in exports. 💊📈 With growing interest from global companies, the sector is stepping confidently beyond borders and onto the world stage — a true testament to our industry’s dedication and innovation. ✨ Pakistan’s pharma is not just growing —
Pakistan Pharma Goes Global! 🌍 Read More »
PMC Registration in Pakistan: Complete Guide for Medical Students and Doctors Understanding the Role of PMC The Pakistan Medical Commission (PMC) regulates medical education and professional practice across the country. It replaced the former PMDC in 2019 to bring transparency and efficiency into the system. By digitizing processes, PMC ensures doctors meet ethical and professional
How to Register with the Pakistan Medical Commission Read More »
Pakistan Pharma continues to expand its global reach through key strategic partnerships that benefit both local industry and international markets. In a progressive move to deepen international collaboration, the Pakistan Pharmaceutical Manufacturer Association (PPMA) welcomed the establishment of the Pakistan–UK Business Advisory Council. This forum is set to enhance bilateral trade in pharmaceuticals and healthcare,
Strengthening Global Ties in Pharma Read More »
PPMA Leadership, led by key executive members, held a productive meeting with DRAP Additional Director Dr. Obaid Ali to discuss regulatory reforms, industry challenges, and future collaboration to uplift Pakistan’s pharmaceutical sector. This strategic meeting marks a significant development in the ongoing efforts to strengthen regulatory coordination in the pharma industry of Pakistan. With the
Pakistan Pharma Industry plays a vital role in national healthcare delivery. With rising demand, the pharmaceutical market in Pakistan continues to expand rapidly. The country now focuses on self-sufficiency in medicine manufacturing. This growth ensures accessibility, affordability, and economic stability. Moreover, key reforms by the Pakistan Pharmaceutical Manufacturer Association (PPMA) show promising impact. Let’s explore
Pakistan Pharma Industry: A Comprehensive Overview Read More »
PPMA appreciates the Finance Minister’s recognition and remains committed to strengthening public–private partnerships for a healthier, self-reliant Pakistan.
Pakistan’s pharma sector stands as a pillar of innovation and skilled growth! Read More »
The Pakistan Pharmaceutical Industry is uniquely positioned to address this national pain point. With promising reforms, digital transformation, and investment support, the industry is on a strong growth path. Public-private partnerships and research-driven models offer new hope for both patients and producers. Moreover, the Pakistan Pharmaceutical Manufacturers Association (PPMA) serves as a key body in
Opportunities in Pakistan’s Pharmaceutical Industry Read More »
The government aims to raise pharma exports from $355M to $3B annually with the launch of PharmEx Pakistan. A dedicated Exporter Facilitation Desk will tackle regulatory and market access challenges, accelerating global growth for the industry.
PharmEx Pakistan Launched to Boost Exports Read More »
The pharmaceutical industry, led by PPMA Chairman Tauqeer Ul Haq, has urged reforms to the Central Research Fund (CRF), proposing that the 1% mandatory contribution be redirected to in-house R&D. This move aims to boost innovation, ensure global regulatory compliance, and reduce bureaucratic inefficiencies.
Pharma industry calls for R & D fund overhaul to drive innovation Read More »
Pakistan Pharmaceutical Manufacturer Association (PPMA) was established on January 26, 1961, and registered as the sole representative of the pharmaceutical industry on July 18, 1961.
